Novel CD28 antagonist mPEG PV1-Fab’ mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production

DOI: 10.1371/journal.pone.0171822

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text